Parkinson’s Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response

Table 2

SCOPA ratings at the end of each week.

Case	Week 1	Week 2	Week 3	Week 4	Week 5	Week 6	Week 7
101	14	11	10	15	12	17	14
102	25	29	20	25	28	22	19
103	42	46	49	48	52	49	47
104	26	29	32	32	33	34	33
105	23	20	22	22	25	28	23
106	29	25	27	28	30	27	33
107	20	18	17	17	11	15	15
108	27	20	16	17	12	15	10
109	16	14	14	17	16	15	13
110	16	10	15	12	12	14	12
112	30	18	21	24	19	19	16
113	21	16	17	20	19	26	21
114	28	20	21	17	20	20	23
115	30	27	30	28	30	29	28
117	13	9	9	7	7	7	8
118	17	20	18	13	14	18	23
Av.	23.6	18.92	21.1	21.3	21.3	22.2	21.1
S.E.	1.9	2.3	2.4	2.4	2.9	2.5	2.6
Data for subgroup analysis:
Av.	20.8	17.1	16.7	17.1	16.25	18	16.4
S.E.	1.7	1.6	1.2	1.5	1.8	1.6	1.5
		0.007	0.0008	0.004	0.007	0.058	0.016

values, using matched, one tail students -test).
Four severe cases (and nonresponders; 104, 106, 103, and 115) were removed for the subgroup analysis.